In clinical studies, 400mg taken daily with diet and exercise supported meaningful reductions in BMI, waist, and hip measurements after just four weeks
Weight loss by retatrutide dose (Phase 2 data at 48 weeks) The most remarkable finding in this data is the last column
The heart-protective effects provide defense against cardiovascular disease through reduced inflammation and improved cholesterol profiles
Understanding GLP-1 and Dual Agonist Medications Semaglutide (the active ingredient in Ozempic, Wegovy, and Rybelsus) mimics a natural GLP-1 hormone that regulates blood sugar and appetite
The effect of prepregnancy body mass index on the risk of gestational diabetes mellitus: a systematic review and dose-response meta-analysis
Industry analysts project a potential launch in 2028, though timelines could shift depending on regulatory review